INTRODUCTION
Recent diagnostic systems in psychiatry include numerous disorders and subtypes of schizophrenia (SZA), bipolar disorder (BPD) and major depressive disorder (MDD) and their overlap to represent the spectrum of expression of mood and psychotic disorders. However, the discrete boundaries between the broad categories of these disorders have been increasingly disputed with the emergence of results from molecular genetic studies, 1 particularly recent large genome-wide association studies that demonstrate common polymorphisms underlying the broad range of psychotic and mood disorders. 2 Previous family studies of the specificity of these conditions have been contradictory, with studies suggesting some specificity of these disorders (for example, SZA, [3] [4] [5] [6] 4 and schizoaffective (SAF) disorder 7 ), whereas others have demonstrated significant familial overlap across these conditions. [8] [9] [10] [11] [12] [13] [14] [15] Likewise, overlap has been found between SZA and SAF. 4, 16 Therefore, SZA, BPD and MDD have been postulated to belong to the same continuum. 17 Most of this research was based on earlier diagnostic systems, including the Research Diagnostic Criteria ( 18 ), and the Diagnostic and Statistical Manual of Mental Disorders (DSM)-III and III-R criteria, that specified different conventions for the diagnosis of psychotic symptoms that occurred in the context of mood disorders. Such conventions as well as the exclusion of anxiety disorders that occur solely during mood disorders 19 led to important differences in the classification and familial aggregation of these disorders over time. 20 There are few controlled direct interview family studies that used the most recent DSM-IV nomenclature to evaluate the relationships of the full range of disorders across the mood disorder spectrum, including SAF disorder, psychotic and nonpsychotic BPD and major depression. Moreover, no previous study has examined the familial aggregation patterns of the core components of these conditions without applying the arbitrary distinctions specified in the diagnostic nomenclature. Therefore, the goals of this report are: (1) to assess the familial aggregation and co-aggregation patterns of the full spectrum of mood disorders based on contemporary diagnostic criteria; and (2) to evaluate the familial specificity of their major subgroups, including psychotic, manic and major depressive episodes (MDEs).
METHODS Participants
There were a total of 403 probands, including 293 patients with mood disorders and 110 controls selected from the local psychiatric and orthopedic departments. Probands with mood disorders were consecutively recruited from the inpatient (61%) and outpatient (39%) facilities of the psychiatric departments of Lausanne and Geneva, Switzerland. These psychiatric university departments cover the majority of inpatient treatments of the population of these respective regions. More severe patients and more patients who have been hospitalized are treated in the outpatient units of Lausanne and Geneva than by the private psychiatrists in this area. Inclusion criteria for psychiatric probands were: (1) a lifetime diagnosis of SAF (SAF disorder, manic subtype (with at least one manic episode); SAF disorder, depressive episode (with at least one MDE of substantial duration of the total duration of psychosis)), BPD-I, BPD-II or MDD, (2) age between 18 and 65 years, (3) ability to speak sufficient French or English to complete the diagnostic interview, and (4) having a first-degree adult relative who agrees to participate in the study. Diagnoses of SAF, BPD-I, BPD-II and MDD were assigned according to the DSM-IV, with the exception of criterion A for SAF regarding the concomitant manifestation of a major mood disorder during an uninterrupted period of SZA.
A sample of inpatients (10%) and outpatients (90%) were recruited from the orthopedic departments of hospitals in Lausanne and Geneva during the same time period to serve as a comparison or control group (n ¼ 110). Inclusion and exclusion criteria were the same as for the mood disorder probands with the exception of the lack of a history of a mood or psychotic disorder. Non-psychiatric medical controls were included in order to control for the inpatient setting of proband recruitment. Orthopedic settings were selected for recruitment of controls because of their similar age composition, and orthopedic conditions have not been shown to be differentially associated with mood disorders whereas disorders from most other specialties have high rates of comorbidity with mood disorders.
There were a total of 1734 adult first-degree relatives (parents, siblings and offspring 418 years) of the probands on whom diagnostic information could be collected. This research project was approved by the local institutional review board. All participants gave written informed consent for their participation before the assessments. There were very few differences between the patients who participated in the family study compared with those who did not. Patients with mood disorders who had at least one participating adult relative (N ¼ 403) did not differ from those with the same mood disorders who had no participating family member (N ¼ 261) regarding sex, age or the presence of comorbid alcohol or drug use disorders. However, BPD-I patients with participating relatives were more likely to have higher socio-economic status than the other BPD-I patients. Moreover, MDD patients with participating relatives were more likely to suffer from comorbid anxiety disorders than the other MDD patients.
Procedures
Participants were interviewed by masters-level psychologists or psychiatrists who completed intensive training over a 3-month period. Training included supervision of videotaped interviews by clinically experienced senior psychologists. Interviewers were blind to the disease status of the family members in any given family. Diagnostic information on probands and interviewed first-degree relatives was obtained using the Diagnostic Interview for Genetic Studies (DIGS, 21 ). There were high kappa coefficients for inter-rater reliability and slightly lower coefficients for test-retest reliability for major Axis-I diagnoses, including major mood and SAF disorders 22 as well as substance use disorders (SUD; 23 ) on the French translation of the DIGS. 24 The only disorder with poor test-retest reliability was BPD-II.
Family history information on probands and all first-degree relatives was collected from all participants using the Family History-Research Diagnostic Criteria (FH-RDC 25 ), which allowed us to obtain diagnostic information on non-interviewed relatives. The validity of the French version of the FH-RDC has previously been established through the assessment of agreement between diagnoses relying on direct interviews and family history reports for a series of diagnoses in adults 26, 27 and children. 28 These analyses as well as similar analyses for mood diagnosis have also allowed us to lower the diagnostic thresholds for disorders in order to minimize information bias due to the low sensitivity of the family history method. DSM-IV diagnoses were assigned according to a bestestimate procedure, 29 which was based on review of information from direct interviews, family history reports and medical records for subjects who had been treated for a psychiatric disorder. The diagnoses of noninterviewed family members were based on all available family history reports based on the FH-RDC.
Data analysis
Analyses were conducted for (1) specific DSM-IV major mood disorders, and (2) major mood or psychotic episodes independently of the disorder during which they occurred. Univariate between-group analyses were performed using chi-square tests or analysis of variance as appropriate. In order to simultaneously assess the effects of the probands' mood disorders or mood/psychotic episode types on the risk of disorders or episodes in family members, generalized linear mixed models (generalized estimating equation procedure 30 ) were applied. These models account for the lack of independence of the observations (varying number of relatives across families). All models were adjusted for the effects of sex and age in relatives as well as for the effects of comorbid anxiety disorders (including generalized anxiety disorder, agoraphobia, panic disorder and/or social phobia), alcohol abuse/dependence and drug abuse/dependence (marijuana, cocaine, narcotics, solvents, hallucinogens, stimulants and sedatives) in both probands and relatives. Statistical analyses were performed using the Statistical Analysis System, version 9.2 (SAS Institute, Inc., Cary, NC, USA).
RESULTS
The demographic characteristics of the probands and the relatives as well as the prevalence of comorbid anxiety and SUD are provided in Table 1 . The probands did not differ by either age (mean age of all probands ¼ 40.0 years, s.d. ¼ 11.9 years) or sex (48.6% females overall). However, a greater proportion of probands with mood disorders had a lifetime history of comorbid anxiety and SUD compared with controls. Among the 100 BPD-I probands, 58% reported psychotic symptoms and 13 (13%) had manic episodes without a history of a MDE (that is, unipolar mania). Among the 62 SAF probands, 7 (11.3%) had only , but the proportion of those with a direct interview differed across groups. Indeed, the proportion of interviewed relatives was highest in the families of probands with SAF, followed by those of probands with BPD-I, BPD-II, MDD and controls. Table 2 provides the lifetime prevalence of DSM-IV mood disorders in relatives according to the proband's disorder status as well as the results from generalized linear mixed models that assessed the associations between disorders in probands and their first-degree relatives, adjusting for demographic characteristics in relatives, anxiety and SUD in both probands and relatives and within-family correlations. The risk of SAF was largely increased in the relatives of probands with the same disorder but not in the relatives of probands with other mood disorders. Furthermore, the risk of BPD-I was largely increased in the relatives of probands exhibiting the same disorder and significantly increased in the relatives of probands with SAF. The risk of BPD-II was significantly elevated only in relatives of probands with SAF but not in those of probands with BPD-II or any other disorder. Moreover, the risk of MDD was approximately doubled in the relatives of probands with BPD-II and MDD. Additional analyses showed that the lack of an association between MDD and BPD-I was independent of the presence of psychotic symptoms in BPD-I probands as the rates of MDD were almost identical (23.2% vs 22.5%) for relatives of BPD-I probands with and without psychotic features. Table 3 presents the rates of specific DSM-IV mood and psychotic episodes in relatives by type of episode in probands as well as the results of the generalized linear mixed models that assessed the associations between these episode types in probands and relatives. As psychotic, manic, hypomanic and depressive episodes were analyzed in a non-hierarchical way, the number of relatives of probands with MDE included those of the probands with MDD and BPD-II as well as those of the probands with BPD-I and SAF who had also experienced MDE. Moreover, given that subjects with hypomania but no history of MDE were not excluded from the controls in the previous disorder-based analyses, the number of relatives of probands with hypomania (Table 3 ) was larger than that of relatives of probands with BPD-II disorder (Table 2) .
First, the risk of psychotic episodes was increased almost three times in the relatives of probands with psychosis, after adjustment for demographic variables in relatives, comorbid disorders in probands and relatives and for manic, hypomanic and depressive episodes in relatives. There was also a high rate of psychosis among the relatives of probands with mania, although this risk was significantly diminished in the generalized linear mixed model after adjustment for comorbid mania in relatives.
The non-hierarchical adjusted analyses also revealed a strong specific familial aggregation of manic episodes. In addition, there was a high rate of mania among the relatives of probands with psychosis, but this risk diminished to 1.0 when manic episodes in probands were simultaneously entered into the generalized linear mixed model. The risk of hypomania was not significantly increased in the relatives of probands with any type of episode compared with the relatives of controls according to the generalized linear mixed models. Finally, the risk of MDE was significantly elevated only among the relatives of probands with MDE after adjustment for demographic variables in relatives, comorbid disorders in probands and relatives and for psychotic, manic and hypomanic episodes in relatives.
Although the crude rates revealed a significant increase of MDE among the relatives of probands with all the other episode types as compared to those of probands with no mood episodes, this risk was almost entirely attributable to strong intra-individual associations between MDE and comorbid mania/hypomania in these relatives. Additional analyses showed that, within the families of manic and psychotic probands, the relatives who exhibited mania or hypomania themselves revealed much higher rates of MDE than the other relatives of these probands. Similarly, within the families of probands with hypomania, MDE and controls the relatives affected with mania or hypomania themselves revealed very high rates of MDE as compared to relatives of these probands who had no comorbid mania/hypomania.
DISCUSSION
To our knowledge, this is the first study to assess the familial aggregation patterns of the full spectrum of mood disorders, as well as their major components within the same sample, using contemporary family study methods and classification systems. The most salient finding of this paper is the familial specificity of psychotic, manic and MDEs, without evidence for shared familial risk across these manifestations of mood disorders. This suggests that there are distinct underlying etiological pathways for the major subtypes of mood disorders that should be pursued in future research on these disorders.
The results of the present study confirm those of previous family studies regarding the specificity of familial aggregation of psychosis, [3] [4] [5] [6] BPD, 3,4,11 and major depression. 11, 12 However, our Abbreviations: CI, confidence interval; MDD, major depressive disorder; OR, odds ratio. *Po0.05; ***Po0.001.
a Models adjusted for sex and age in relatives and anxiety disorders (generalized anxiety disorder, agoraphobia, panic disorder and/or social phobia), alcohol abuse/dependence and drug abuse/dependence in both probands and relatives. 31 suggests that the familial independence in the present study is likely to tap differential genetic risk factors that contribute to manic and MDEs. The lack of evidence for a common diathesis underlying the 'pure' forms of these disorders 9, 17, 32 supports the conclusion of a recent comprehensive review regarding the independence of BPD-I, SAF and SZA based on evidence for differential treatment response and neuroimaging findings. 33 The independence of psychosis from mania and major depression further suggests that independent characterization of these domains of cognitive and mood disturbances may be more valid than the use of the categories of BPD and SZA specified in current diagnostic systems.
Although the present report focused on psychotic episodes that occurred within the bounds of SAF and other mood disorders, inclusion of a small sample of families of patients with SZA yielded similar findings for psychosis (odds ratio (OR) ¼ 2. The lack of specific familial clustering together with the poor test-retest reliability of the BPD-II subgroup defined by the DSM-IV 22 (and unchanged in the DSM-5 34 ) cast doubt on the validity of the BPD-II subtype. Rather, the evidence of shared underlying diatheses between BPD-II and MDD suggests that hypomanic mood episodes that alternate with episodes of major depression are likely to represent a particular clinical manifestation of MDD rather than a subgroup of BPD. This is the first contemporary family study of a large clinical sample of probands with a broad range of manifestations of the mood disorder spectrum and with comprehensive diagnostic evaluations on probands and a large proportion of first-degree relatives. Whereas previous studies largely adhered to the diagnostic conventions in place at the time of study enrollment, our analyses of the key components of these conditions demonstrate the importance of suspension of arbitrary diagnostic distinctions. There are also several limitations of this study that should be considered in interpreting these findings. First, despite large efforts to directly interview all first-degree relatives, a substantial proportion of them were not available for such an assessment, and the diagnoses of these relatives needed to be assigned according to family history reports. In addition, the proportion of interviewed relatives varied across study subgroups. However, we have minimized the risk of differential bias due to differential participation of relatives by applying an extensively validated diagnostic best-estimate procedure that adjusted the diagnostic threshold for specific disorders in function of the source of available information. 26, 27 Second, the evaluation of subjects was cross-sectional, which may have diminished the accuracy of collected diagnostic data due to the risk of incomplete recall of symptoms. Third, the study was based on treated probands who exhibited substantial comorbidity with anxiety and SUD, which limits the generalizability of our results to less severe forms of mood disorders in the community. Fourth, our sample had fairly small numbers of family members of probands in the bipolar-II diagnostic group, thereby limiting our ability to investigate the familial clustering of this disorder. Fifth, the small number of unipolar manic patients in this treatment sample reduced our ability to study the independence of mania and depression. 35 This work highlights the importance of combining multiple sources of evidence regarding etiological factors underlying disorders in the development of diagnostic nomenclature and studies of their treatment, course and risk factors. The debate regarding common versus specific diatheses cannot be resolved by any one approach, such as genome-wide association studies that implicate numerous common polygenic markers across disorders, 2 particularly in light of the low relative and attributable risk of such markers. The specificity of treatment and neuroimaging findings suggest the utility of retaining distinctions between these conditions. 33 However, it is likely that the multifactorial etiology of these conditions will be based on both unique and common environmental and genetic risk factors. Our findings demonstrate that continued dissection of the core features of these conditions will be essential to our future understanding of their etiology, course and treatment.
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